NOF CORPORATION is a Manufacturer/Innovator company operating in the pharmaceutical industry.
The NOF Group pursues multifaceted business development in eight divisions of activities based on its own technologies. NOF CORPORATION is the leading commercial supplier of Drug Delivery Products, including linear and branched hetero-activated PEGs, single molecule PEG linkers for the development of next generation Antibody Drug Conjugates (ADCs), phospholipids nanoparticle formulations, and SS-cleavable lipids for nucleic acid and gene deliveries.
Company type
Manufacturer/Innovator
Products and services
Biopharmaceuticals, Intermediates, Fine and Specialty Chemicals, Pharmaceutical Packaging
Markets
Oceania, North America (USA, Canada), Africa, Middle East Region (e.g. UAE), Central America (e.g. Mexico), East Asia (e.g. China, Japan, Korea), Europe – EU countries, Europe – non EU (e.g. UK, Russia, ex-CIS countries), South America (e.g. Brazil, Colombia), South Asia (e.g. India, Pakistan, Sri Lanka), South East Asia (e.g. Thailand, Philippines, Singapore)
Address
NOF CORPORATION, Hamburger Allee 2-4, Frankfurt am Main, Germany, 60486